Home > 시장보고서 > 파머슈티컬 > 제약회사분석 > The CRO Market Outlook: Emerging markets, leading players and future trends

전화 문의

시장보고서

The CRO Market Outlook: Emerging markets, leading players and future trends

리서치사	Business Insights
발행일	2009년 08월	상품코드	99393
페이지 정보	167 pages
가격	US $ 3,835 ￦ 4,569,400 PDF by E-mail (Single User License) US $ 14,381 ￦ 17,134,900 PDF by E-mail (Global Site License)

한글목차
영문목차
관련자료

영문목차

Abstract

Introduction

Rising costs and falling productivity, among other trends are driving pharmaceutical companies to outsource an increasing range of functions to CROs in search of time and cost savings. This produced strong double-digit growth in the sector between 2003 and 2008. However, amongst other resistors, the financial crisis resulted in reduced funding available for biotech companies. This fully updated CRO Market Outlook assesses the market drivers and resistors and predicts the effects of these. The report analyzes the overarching trends in the industry; examines which regions are set to see growth in CRO activity; evaluates the leading CROs; and outlines the future of the industry. The report provides insight into conditions into seven emerging regions including China, India and Latin America. It highlights the evolving business and relationship models between CROs and sponsor companies and enables optimal outsourcing strategy.

Key features of this report

Identifies and analyses the most recent trends and issues in outsourcing clinical R&D
Describes where clinical trials will be conducted in the future
Explores the complexities and the costs of outsourcing R&D to different world regions
Profiles the major international CRO players
Provides a detailed assessment of the current CRO market including market share information and the size/growth of R&D spending
Focuses on emerging CRO markets
Highlights evolving strategies for working with CROs
Examines existing and future CRO business models

Key findings from this report

The total CRO market size is estimated at $20bn in 2008 and expected to grow at an annual rate of 8.5% to reach $35bn through 2015. The market is highly fragmented and the number of CROs worldwide has reached over 1,100 despite continued consolidation.
CROs provide substantial global capacity to drug developers and have become a critical contributor to clinical trial activity. Projects with high CRO involvement are associated with shorter development times.
Of the large, global contract research providers, Quintiles is market leader, with 15% of the global market share, followed by Covance and PPD. The five largest CROs have increased their market share and now hold 55% of the total market.
The leading CROs are commodity full service providers operating on a global scale. They act as one-stop shops for all services, from preclinical through marketing.
The number of clinical studies conducted in Asia, Central and Eastern Europe and Latin America is constantly rising. India and China are the future outsourcing destinations of choice.
CROs and pharmaceutical companies are turning to strategic partnerships to gain a competitive edge in the global business environment.

Executive Summary

The global contract research organization market
CRO market analysis
Established regions in the global CRO market
Emerging regions in the global CRO market
Leading players in the global CRO market
The future of contract research

Chapter 1 - The global contract research organization market

Summary
Introduction
The CRO contribution to drug development
Market overview
Key market drivers
Key market restraints
Conclusions and key findings

Overview of the global CRO market
Total revenue forecasts
Global R&D expenditure and CRO market size
Global clinical development outsourcing
The contribution of CRO to drug development

Current market drivers
Growth of R&D expenditure from biotech and pharma
Cost pressures encourage R&D outsourcing
Long term growth and R&D expenditure of biotechnology companies
Growing regulatory burden and safety concerns
- US
- EU
Patient recruitment
Increasing number of products in development
The development of biomarkers

Current market restraints
Near term reductions in biotech R&D spending
Growing competition and customer consolidation
New financial realities alter biopharmaceutical outsourcing landscape
Shortage of clinical research personnel
Electronic data capture: a threat to CRO revenue

Key market trends
Globalization
EDC evolution
Strategic alliances

Chapter 2 - CRO market analysis

Summary
Introduction
Market conditions

Competitive analysis
Market share analysis
Competitive dynamics
- Academic medical centers
- Site management organizations
- Laboratory analytical services
- Non-CRO niche service providers
- Conclusion

CRO service models
Introduction
The full service model
- SWOT analysis
The niche model
- SWOT analysis

Industry strategies
Consolidation: Mergers & acquisitions in the CRO industry
Expanding the continuum of services: vertical integration
- Forward integration
- Backward integration

Industry challenges
Consolidation within the CRO industry: a threat to close customer relationships
Strategic outsourcing: demonstrating clear value to clients
Co-development: sharing the risk

Chapter 3 - Established regions in the global CRO market

Summary
Introduction

The US CRO market
Overview
Drivers of the US CRO market
Challenges of the US CRO market
Competitive dynamics

The CRO market in Western Europe
Overview
Infrastructure and local regulations
Drivers of the CRO market in Western Europe
Challenges of the CRO market in Western Europe
Competitive dynamics

Chapter 4 - Emerging regions in the global CRO market

Summary
Introduction

The Central and Eastern European CRO market
Overview
Infrastructure and local regulations
Benefits of outsourcing to CEE
Challenges of outsourcing to CEE
Competitive dynamics

The CRO market in China
Overview
Infrastructure and local regulations
Benefits of outsourcing to China
Challenges of outsourcing to China
Competitive dynamics

The CRO market in India
Overview
Infrastructure and local regulations
- Intellectual property
- Legislative reforms
Benefits of outsourcing to India
Challenges of outsourcing to India
Competitive dynamics

The CRO market in Latin America
Overview
Infrastructure and local regulations
- Argentina
- Brazil
- Mexico
Benefits of outsourcing to Latin America
Challenges of outsourcing to Latin America
Competitive dynamics

The CRO markets in South Korea and Turkey
Overview
Infrastructure and local regulations
Benefits of outsourcing to South Korea
Challenges of outsourcing to South Korea
Benefits of outsourcing to Turkey
Challenges of outsourcing to Turkey
Competitive dynamics

Chapter 5 - Leading players in the global CRO market

Summary

Introduction
The client perspective
Capabilities of leading CROs

Quintiles Transnational Corp
Company profile
Business description
Partnering collaborations and recent deals

Covance
Company profile
Business description
Partnering collaborations and recent deals

PPD Inc.
Company profile
Business description
Partnering collaborations and recent deals

Charles River Laboratories
Company Profile
Business description
Partnering collaborations and recent deals

PAREXEL International
Company profile
Business description
Partnering collaborations and recent deals

ICON plc.
Company profile
Business description
Partnering collaborations and recent deals

MDS Inc.
Company profile
Business description
Partnering collaborations and recent deals

Kendle International
Company profile
Business description
Partnering collaborations and recent deals

PRA International
Company profile
Business description
Partnering collaborations and recent deals

PharmaNet Development Group
Company profile
Business description
Partnering collaborations and recent deals

Chapter 6 - The future of contract research

vSummary
Introduction
The shift towards a strategic model
Emerging markets
Phases I and IV growth activity
Electronic data capture

Biomarkers
Selected acquisitions/partnerships
Conclusion

Key findings and conclusions

Chapter 7 - Appendix

Selected bibliography
Index

List of Figures

Figure 1.1: Estimated CRO market ($bn), 2003-2015e
Figure 1.2: Global development expenditure and CRO market forecast ($bn), 2008-2014e
Figure 1.3: Global outsourcing market by phase, 2006
Figure 1.4: CRO usage and number of days by which projects overrun
Figure 1.5: Global pharmaceutical R&D expenditure ($bn), 2000-2014e
Figure 1.6: Number of FDA approvals 1990-2008
Figure 1.7: Comparison of drug development cost estimates
Figure 1.8: Global biotech R&D expenditure ($bn), 2004-2012e
Figure 1.9: Number of products in development by phase 1998-2009
Figure 1.10: CRO/Sponsor relationship models
Figure 2.11: Market share of major players, 2008
Figure 2.12: Typical full service CRO model
Figure 3.13: R&D expenditures of PhRMA members and non-member companies ($bn), 1980-2009
Figure 3.14: Overall indexed clinical trial costs by region, 2006-2008
Figure 3.15: The European CRO market - revenue forecast ($bn), 2008-2012e
Figure 3.16: Pharmaceutical R&D expenditure in Europe ($bn), 1990-2008
Figure 4.17: Geographic distribution of clinical trials, 2005 to 2009f
Figure 4.18: Clinical trial costs of European countries compared to the UK
Figure 4.19: Comparison of trial registration periods in CEE countries (days)
Figure 4.20: CRO market in China ($m), 2007-2012e
Figure 4.21: China' s capabilities across the value chain
Figure 4.22: India' s capabilities across the value chain
Figure 4.23: Number of clinical trials in Latin America, 2000-2008
Figure 4.24: Clinical trials in South Korea, 2005-2009e
Figure 5.25: Revenue growth of top public CROs in 2007-2008
Figure 5.26: Capabilities of leading CROs, 2009
Figure 6.27: Regional presence of major CROs
Figure 6.28: Attractiveness of selected countries for clinical trials
Figure 6.29: Global numbers of phase IV trials 2006-2009e
Figure 6.30: Electronic data capture market size ($m), 2006E-2012e
Figure 6.31: Clinical trials using predictive biomarkers, 2005-2009